Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prognostic Stage IIIA Breast Cancer AJCC v8”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT02515110
What this trial is testing

Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer

Who this might be right for
Breast CancerNode-positive Breast CancerBreast Adenocarcinoma+2 more
Virginia Commonwealth University 137
Testing effectiveness (Phase 2)UnknownNCT04197687
What this trial is testing

TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery

Who this might be right for
Breast AdenocarcinomaStage II Breast Cancer AJCC v6 and v7Stage IIA Breast Cancer AJCC v6 and v7+5 more
Academic and Community Cancer Research United 480
Early research (Phase 1)Study completedNCT03518242
What this trial is testing

Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer

Who this might be right for
Breast Cancer FemaleAnatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+9 more
Fred Hutchinson Cancer Center 100
Early research (Phase 1)Ended earlyNCT01208441
What this trial is testing

RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerProgesterone Receptor-positive Breast Cancer+2 more
National Cancer Institute (NCI) 28
Not applicableEnded earlyNCT00891969
What this trial is testing

Treatment Decision Making Between Oncologists and Women With Newly Diagnosed Breast Cancer and Their Healthy Companions

Who this might be right for
Breast Cancer
Rutgers, The State University of New Jersey 77
Testing effectiveness (Phase 2)WithdrawnNCT00080613
What this trial is testing

Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer

Who this might be right for
Stage II Breast CancerStage IIIA Breast CancerStage IIIB Breast Cancer+1 more
Robert H. Lurie Cancer Center
Not applicableWithdrawnNCT04560439
What this trial is testing

Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer Survivors

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+18 more
City of Hope Medical Center
Not applicableStudy completedNCT00003538
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Large-scale testing (Phase 3)Study completedNCT00002755
What this trial is testing

Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
Scottish Cancer Therapy Network 600
Not applicableStudy completedNCT00436917
What this trial is testing

Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer

Who this might be right for
Breast CancerOsteoporosis
Mayo Clinic 60
Large-scale testing (Phase 3)Ended earlyNCT00324324
What this trial is testing

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
OHSU Knight Cancer Institute 240
Testing effectiveness (Phase 2)Study completedNCT04294225
What this trial is testing

Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+19 more
Mayo Clinic 161
Testing effectiveness (Phase 2)WithdrawnNCT00075413
What this trial is testing

Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
The University of Texas Medical Branch, Galveston
Testing effectiveness (Phase 2)Ended earlyNCT01151449
What this trial is testing

Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerHER2-negative Breast CancerMale Breast Cancer+7 more
National Cancer Institute (NCI) 6
Not applicableUnknownNCT00005058
What this trial is testing

Enhanced Ultrasound in Determining Extent of Disease in Women With Primary Breast Cancer

Who this might be right for
Breast Cancer
Royal Marsden NHS Foundation Trust
Testing effectiveness (Phase 2)Active Not RecruitingNCT02311933
What this trial is testing

Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer

Who this might be right for
Recurrent Breast CarcinomaStage III Breast Cancer AJCC v7Stage IIIA Breast Cancer AJCC v7+3 more
National Cancer Institute (NCI) 81
Large-scale testing (Phase 3)Study completedNCT00044291
What this trial is testing

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasms, Hormone-dependent
Intarcia Therapeutics 865
Testing effectiveness (Phase 2)Study completedNCT00006110
What this trial is testing

Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 82
Not applicableLooking for participantsNCT02918474
What this trial is testing

Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+20 more
M.D. Anderson Cancer Center 15
Early research (Phase 1)Study completedNCT04205903
What this trial is testing

Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+17 more
Ohio State University Comprehensive Cancer Center 11
Next Page